Supplementation with Omega-6 PUFAs indicated an increase in the AA levels in GDM which is associated with improved insulin sensitivity, glucose levels, and reducing obesity [40]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.